Cent Co-Founders (L-R): Arpit Garg, Shashank ND, and Anshul Khandelwal

The Health-Tech Pulse: Summary (TL;DR)

Key Highlight: Bangalore-based health-tech startup Cent has secured USD 5 Million in seed funding led by OneFlow Holdings and South Park Commons. Founded by Practo co-founder Shashank ND, Cent utilizes a proprietary CCNM protocol—combining AI, imaging, and 120+ biomarkers—to screen for over 300 health conditions in a single visit. The startup aims to conduct 10 million scans and save one million lives by 2035.

The Indian healthcare landscape is shifting from "reactive treatment" to "proactive prevention." Cent, a pioneering health-tech startup, has announced a $5 million seed funding round to scale its AI-driven early disease detection platform across India.

Founded by industry veterans Shashank ND and Arpit Garg, the company is designed to fill a critical gap: detecting life-threatening conditions before symptoms even appear.

The Technology: 300+ Conditions, One Visit

At the heart of Cent’s operations is its proprietary CCNM Protocol (Cardiac, Cancer, Neurological, and Metabolic). Unlike traditional check-ups, Cent’s workflow integrates:

• Advanced Imaging: Whole-body MRI, low-dose CT scans, and DEXA scans.

• Biochemical Data: Over 120 blood and urine biomarkers.

• AI-Assisted Radiology: Artificial intelligence-based analysis to identify risks for chronic conditions at an early stage.

According to Arpit Garg, Co-founder and Chief AI Officer, this level of integration—combining multi-omics analysis with AI—was technically impossible just five years ago but is now the gold standard for preventive care.

Proven Impact: Clinical Findings

Since becoming operational in early FY26, Cent has already completed over 1,500 scans. The data underscores the necessity of early screening:

• 26% of screenings revealed "clinically meaningful findings" in asymptomatic individuals.

• 3-4% of screenings identified critical, life-threatening conditions requiring immediate medical intervention.

Expansion Strategy: Bengaluru to Pan-India

With the fresh injection of $5M from OneFlow Holdings and South Park Commons, Cent is set to expand its physical and digital footprint:

1. Specialized Centers: Launching state-of-the-art facilities in Bengaluru, Mumbai, and Delhi.

2. Phase 2 Cities: Expanding into Pune and Hyderabad.

3. Infrastructure: Scaling engineering teams to enhance AI diagnostic accuracy and deepening healthcare partnerships.

At a Glance: Cent Startup Profile

Frequently Asked Questions (FAQ)

Q: What is Cent?

A: Cent is a Bangalore-based health-tech startup that focuses on early disease detection using a combination of AI, advanced medical imaging, and multi-biomarker analysis.

Q: Who are the founders of Cent?

A: Cent was founded by Shashank ND (the co-founder of Practo) and Arpit Garg.

Q: What is the CCNM protocol?

A: The CCNM protocol is Cent's specialized screening method that targets Cardiac, Cancer, Neurological, and Metabolic conditions simultaneously.

Q: How many conditions can Cent detect in one visit?

A: Using its AI-driven platform, Cent can screen for over 300 potential health conditions in a single visit through a direct-to-consumer model.

Q: Where are Cent’s health centers located?

A: Cent is currently establishing specialized centers in Bengaluru, Mumbai, and Delhi, with plans to expand to Pune and Hyderabad shortly.

Q: Why is Cent's model different from traditional hospitals?

A: Traditional healthcare is often symptom-led. Cent’s model is built on a dedicated, high-utilization workflow designed specifically for early detection in asymptomatic people, allowing for lower costs and higher diagnostic rigor.